LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Search

MannKind Corp

Fechado

SetorSaúde

4.37 -4.17

Visão Geral

Variação de preço das ações

24h

Atual

Mín

4.35

Máximo

4.56

Indicadores-chave

By Trading Economics

Rendimento

5.7M

13M

Vendas

1.6M

78M

P/E

Médio do Setor

48.1

56.602

EPS

0.04

Margem de lucro

16.793

Funcionários

403

EBITDA

8.3M

27M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+119.3% upside

Dividendos

By Dow Jones

Próximos Ganhos

6 de ago. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-45M

1.5B

Abertura anterior

8.54

Fecho anterior

4.37

Sentimento de Notícias

By Acuity

38%

62%

130 / 382 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

MannKind Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

15 de mai. de 2025, 22:52 UTC

Ganhos
Grandes Movimentos do Mercado

Virgin Galactic Shares Rise on Commercial Spaceflight Plans, Narrower 1Q Loss

15 de mai. de 2025, 20:37 UTC

Principais Notícias
Ganhos

Applied Materials Logs Higher 2Q Profit, Revenue as Customer Demand Remains Unchanged

16 de mai. de 2025, 00:00 UTC

Conversa de Mercado

Xero Bull Stays Positive on Cost Outlook -- Market Talk

15 de mai. de 2025, 23:47 UTC

Conversa de Mercado

Gold Consolidates; Likely Supported by Signs of Disinflation -- Market Talk

15 de mai. de 2025, 23:38 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

15 de mai. de 2025, 23:38 UTC

Conversa de Mercado

Nikkei May Edge Higher, Tracking Gains Across Most U.S. Equity Markets -- Market Talk

15 de mai. de 2025, 23:14 UTC

Principais Notícias

Walmart Becomes Biggest Retailer Yet to Pass Through Tariff Price Increases -- 4th Update

15 de mai. de 2025, 22:46 UTC

Principais Notícias
Aquisições, Fusões, Aquisições de Empresas

Bayer Seeks New Roundup Settlement While Exploring Monsanto Bankruptcy -- WSJ

15 de mai. de 2025, 22:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Bayer Working With Restructuring Advisers Latham, AlixPartners to Explore Options for Monsanto -- WSJ

15 de mai. de 2025, 22:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Bayer Exec Says Company Committed to Resolving Roundup Lawsuits in 18 Months -- WSJ

15 de mai. de 2025, 22:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Bayer Seeks New Roundup Settlement While Exploring Monsanto Bankruptcy -- WSJ

15 de mai. de 2025, 21:58 UTC

Ganhos

Applied Materials Earnings Beat Expectations. Why the Stock Is Down. -- Barrons.com

15 de mai. de 2025, 21:24 UTC

Ganhos

Cava's Earnings Beat Expectations. Growth Was Strong Despite Tariff Fears. -- Barrons.com

15 de mai. de 2025, 20:56 UTC

Conversa de Mercado

U.S. Spending Downturn Could Lie Ahead -- Market Talk

15 de mai. de 2025, 20:54 UTC

Conversa de Mercado
Ganhos

Applied Materials CFO Says Demand Stable Despite Tariffs, Macro -- Market Talk

15 de mai. de 2025, 20:54 UTC

Ganhos

Applied Materials Investing to Support Semiconductor Market of More Than $1T by End of Decade, Financial Chief Says

15 de mai. de 2025, 20:51 UTC

Ganhos

Applied Materials Financial Chief: Long-Term Secular Growth Drivers Remain Intact

15 de mai. de 2025, 20:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

15 de mai. de 2025, 20:50 UTC

Aquisições, Fusões, Aquisições de Empresas

Berkshire Sells Financial Stocks, Doubles Constellation Stake, Holds Steady on Apple -- WSJ

15 de mai. de 2025, 20:50 UTC

Ganhos

Applied Materials' Customer Investments Continue at Expected Rate and Pace, Financial Chief Says

15 de mai. de 2025, 20:47 UTC

Ganhos

Applied Materials Not Currently Seeing Large Changes in Customer Demand, CEO Says

15 de mai. de 2025, 20:47 UTC

Ganhos

Applied Materials Sees Revenue From Advanced DRAM Customers to Grow 40% in FY25, CEO Says

15 de mai. de 2025, 20:47 UTC

Ganhos

Applied Materials Grew Faster Than Peers in Markets Outside China in 2Q, CEO Says

15 de mai. de 2025, 20:47 UTC

Ganhos

Applied Materials Underperformed Market in China in 2Q Due to Restrictions on U.S. Companies, CEO Says

15 de mai. de 2025, 20:37 UTC

Ganhos

SOS Ltd: Growth Was Fueled by Robust Domestic Demand and Expansion of Pdt Portfolio to Include Rubber and Coal >SOS

15 de mai. de 2025, 20:37 UTC

Ganhos

SOS Ltd: Cryptocurrency Mining Rev Declined to $9.3M From $18.9M in FY23, Dip Was Attributed to the Temporary Shutdown of Texas Mining Facility for Upgrades During 1H 2024 >SOS

15 de mai. de 2025, 20:37 UTC

Ganhos

SOS Ltd: FY24 Significant Yr-over-Yr Increase in Commodity Trading Rev, Which Soared to $214.3M FY24, 92.6% of Total Rev Up From 74.0% in FY23 >SOS

15 de mai. de 2025, 20:37 UTC

Ganhos

SOS Ltd: Cryptocurrency Mining Rev Halves as SOS Focuses on Facility Upgrades and Commodity Expansion >SOS

15 de mai. de 2025, 20:26 UTC

Principais Notícias

Trump Presses Apple to Bring iPhone Manufacturing to America. Wall Street Shrugs. -- WSJ

15 de mai. de 2025, 20:25 UTC

Ganhos

Deere Stock Jumps on Guidance Cut. Here's Why. -- Barrons.com

Comparação entre Pares

Variação de preço

MannKind Corp Previsão

Preço-alvo

By TipRanks

119.3% parte superior

Previsão para 12 meses

Média 10 USD  119.3%

Máximo 12 USD

Mínimo 9 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para MannKind Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

6 ratings

6

Comprar

0

Manter

0

Vender

Pontuação Técnica

By Trading Central

4.079 / 4.323Suporte e Resistência

Curto Prazo

Bullish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Weak Bearish Evidence

Sentimento

By Acuity

130 / 382 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre MannKind Corp

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes, and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults. The company's product pipeline also includes Tyvaso DPI (Treprostinil), an inhalation powder for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; MNKD-101, a nebulized formulation of clofazimine, for the treatment of severe chronic and recurrent pulmonary infections, including nontuberculous mycobacterial lung disease; MNKD-201, a dry-powder formulation of nintedanib, for the treatment of idiopathic pulmonary fibrosis (IPF). In addition, it has collaboration and license agreement with United Therapeutics Corporation for development, regulatory, and commercial activities of Tyvaso DPI; co-promotion agreement with Vertice Pharma to promote Thyquidity; and collaboration agreement with Thirona to evaluate the therapeutic for the treatment of pulmonary fibrosis. Further, the company has supply and distribution agreement with Biomm S.A. for the commercialization of Afrezza in Brazil; and license and distribution agreement with Cipla Ltd. for the marketing and distribution of Afrezza in India. MannKind Corporation was incorporated in 1991 and is headquartered in Danbury, Connecticut.